Robyn Tamblyn

McGill University — Canada

Medicine · Health Sciences

65h-index19.4kcitations352works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Practices and Patient Outcomes(107), Health Systems, Economic Evaluations, Quality of Life(50), Medication Adherence and Compliance(46), Electronic Health Records Systems(39), Primary Care and Health Outcomes(27)

Publications352 total

Is Reversible Cognitive Frailty a Unified Syndrome? Insights from a Bifactor Exploratory Structural Equation Model in People with HIV
2026Open Access
Magnesium Supplementation and Tachyarrhythmias
JAMA Internal Medicine·2025Open Access
Assessing the acceptability and usability of MedSafer, a patient-centered electronic deprescribing tool
JAMIA Open·2025Open Access
Response to: Revisiting Opioid Risk Assessment
Pain·2025Open Access
Identification of medication–microbiome interactions that affect gut infection
Nature·2025· 10 cited
Sedative co-medication patterns across frailty states in people with HIV: a network-based study
International Journal of Clinical Pharmacy·2025
Evaluating the Effectiveness of Mobile Apps on Medication Adherence for Chronic Conditions: Systematic Review and Meta-Analysis
Journal of Medical Internet Research·2025· 2 citedOpen Access
Criteria to Report Adverse Drug Withdrawal Events in Clinical Trials: A Systematic Review
Journal of the American Geriatrics Society·2025· 5 citedOpen Access
Does Physicians' Clinical Competence, Communication Ability, or Cultural Background Influence Potentially Inappropriate Prescribing of Benzodiazepines and Z‐Drugs Among Older Adults With Insomnia?
Pharmacoepidemiology and Drug Safety·2024Open Access
Abstract 4142894: Multimorbidity Trajectories Across the Lifespan in Patients with Congenital Heart Disease
Circulation·2024
Evaluating the effectiveness of the Smart About Meds (SAM) mobile application among patients discharged from hospital: protocol of a randomised controlled trial
BMJ Open·2024Open Access
Comparative risk of mortality in new users of prescription opioids for noncancer pain: results from the International Pharmacosurveillance Study
Pain·2024· 7 citedOpen Access
Impacts of Medications on Microbiome-mediated Protection against Enteric Pathogens
2024· 1 citedOpen Access
Emerging lessons from experiences at transitions in care among hospitalised patients with cancer with postdischarge frequent emergency department use: a qualitative study using linked clinical and patient-reported interview data from Quebec, Canada
BMJ Open·2024· 1 citedOpen Access
Disentangling the Effects of Comorbidity and Polypharmacy on Cognitive Function and Physical Frailty in Individuals With HIV
JAIDS Journal of Acquired Immune Deficiency Syndromes·2024· 4 cited
Cognitive impact of anticholinergic and sedative burden in people with HIV
AIDS·2024· 7 cited
POS1173 COMPARATIVE RISK OF MORTALITY IN NEW USERS OF PRESCRIPTION OPIOIDS FOR NON-CANCER PAIN: RESULTS FROM THE INTERNATIONAL PHARMACOSURVEILLANCE STUDY
Annals of the Rheumatic Diseases·2024
Evaluating the effectiveness of mobile applications on medication adherence for chronic conditions: Systematic Review and Meta-analysis (Preprint)
2024Open Access
Abstract 3468: Emerging lessons from patient-reported hospital discharge experiences among hospitalized cancer patients with frequent emergency department use
Cancer Research·2024
The association between anticholinergic/sedative burden and physical frailty in people aging with HIV
AIDS·2023· 6 cited
page 1 of 18Next →

Frequent Co-authors

Michał Abrahamowicz(12), Allen Huang(11), James A. Hanley(9), Nancy Winslade(8), David L. Buckeridge(8), Gillian Bartlett(7), Peter J. McLeod(7), Tewodros Eguale(6), Andrea Benedetti(4), Dale Dauphinée(4), Nadyne Girard(4), Yvette Bonvalot(4), Roland Grad(4), David Gayton(3), D J Klass(3), Robert B. Perreault(3), Aude Motulsky(3), Ari N. Meguerditchian(3), Mark S. Goldberg(3), Richard T. Burnett(3)